Blood transfusion in sickle cell disease.
DOI:
https://doi.org/10.20344/amp.3308Abstract
Sickle cell disease is a genetic disorder characterized by the presence of hemoglobin S. This hemoglobin has a low affinity for oxygen, allowing a good oxygenation of tissues with low levels of hemoglobin. Therefore, blood transfusions are not necessary to correct basal anemia, but are indispensable in the treatment and prevention of some complications. Detailed indications for blood transfusions are presented, as well as the different types of transfusion usually performed: simple, exchange and hypertransfusion. Finally, reference is made to the preferable blood components to be used, complications related with transfusion, the preventive measures to be taken and the need for a patient's transfusion record.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
